Additional file 1 of Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France
Creators: name: Bosetti, Paolo
name: Tran Kiem, Cécile
name: Andronico, Alessio
name: Colizza, Vittoria
name: Yazdanpanah, Yazdan
name: Fontanet, Arnaud
name: Benamouzig, Daniel
name: Cauchemez, Simon
Publisher: name: figshare
Year: 2022
Subjects: subject: Medicine
subject: Genetics
subject: FOS: Biological sciences
subject: Neuroscience
subject: Biotechnology
subject: Mathematical Sciences not elsewhere classified
subject: Cancer
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Computational Biology

description: Additional file 1: Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France. Table S1: Relative risk of infection, transmission and hospitalization for unvaccinated individuals relative to vaccinated individuals, in different age groups. Figures S1 to S14. Figure S1: Fit to the data. Figure S2: Comparison of the costs of different strategies. Figure S3: Distribution of infections between groups defined by their age and vaccination status. Figure S4: Distribution of hospitalisations between groups defined by their age and vaccination status. Figure S5: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden in a scenario where children aged 0-9 y.o. are 50% less infectious than adults, in addition to being 50% less susceptible. Figure S6: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden in a scenario where children aged 0-9 y.o. and teenagers 10-17 are as susceptible as adults. Figure S7: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden in a scenario where the efficacy of the vaccines against infection is set to 80%. Figure S8: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden in a scenario where the efficacy of the vaccines against hospitalisation is set to 90%. Figure S9: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden in a scenario where the vaccinated individuals transmit the virus as the unvaccinated ones. Figure S10: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden, in the scenario with R0=5 and a vaccine coverage of 80%-90%-90% among 12-17 y.o., 18-59 y.o. and over 60 y.o..Figure S11: Contribution of groups defined by their age and vaccination status to infections, disease spread and hospital burden, in the scenario with R0=5 and a vaccine coverage of 80%-90%-90% among 12-17 y.o., 18-59 y.o. and over 60 y.o and where the efficacy of the vaccines against hospitalisation is set to 90%. Figure S12: Projections in the absence of control measures, as a function of the basic reproduction number R0 and vaccine coverage. Figure S13: Projections in the absence of control measures, as a function of the basic reproduction number R0 and different vaccine coverages in children aged 5 to 11y.o.. Figure S14: Peak in daily hospital admissions under different testing strategies.